Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. POSITIVE TRIAL Pregnancy Outcome & Safety of Interrupting Therapy for Women with Endocrine ResponsIVE Breast Cancer. (Initial Results from the POSITIVE Trial presented by Ann Partridge Harvard Medical …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. For years, breast cancer treatments have been influenced by the information obtained at the time of the original biopsy of the breast cancer. When someone is diagnosed with …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Recently, I attended two conferences about breast cancer, and both covered the special issue related to Pregnancy and Breast cancer. I think we are covering this issue more …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. How Long can you wait for Radiation after Surgery? Radiation treatment has remained an essential treatment particularly for those individuals who are at higher risk of breast cancer …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Dr. Adrienne Waks, breast oncologist at the Dana Farber Cancer Institute, recently presented at the 21st Annual International Future in Breast Cancer East (July 2022). She discussed the …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Of the lectures from the 21st Annual International Congress on the Future of Breast Cancer, East, back in July 2022, a wonderful lecture by Dr. Stephanie Wong, who …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Long-term use of Aromatase Inhibitors (AI) for endocrine blockade for postmenopausal women with hormone receptor positive breast cancer has been a well-established treatment for several decades in the …
Research remains an essential part of cancer care. In this monthly blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Though enormously practice changing, we still have unmet needs and research at NEXT Oncology is looking at better ways to improve immune recognition for better tumor response …
Research remains an essential part of cancer care. In this monthly blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Hormone Positive Breast (HR+) cancer defined by biopsy results of having a breast cancer staining positive for either the Estrogen Receptor (ER) or Progesterone Receptor (PR), or …
Cancer patients and their caregivers often have questions when exploring treatment options, especially when it comes to early-stage clinical trials. The physicians and clinical investigators at NEXT Oncology have pulled together a list of frequently asked questions. In this blog, they answer the questions in a succinct manner, but encourage patients to have more in-depth conversations with their physicians when …
